Insight Molecular Diagnostics, Inc. (IMDX)
5.83
-0.02
(-0.34%)
USD |
NASDAQ |
Jun 10, 16:00
5.83
0.00 (0.00%)
After-Hours: 20:00
Insight Molecular Diagnostics Profit Margin (Quarterly) : -13.41K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -13.41K% |
| December 31, 2025 | -2.02K% |
| September 30, 2025 | -4.17K% |
| June 30, 2025 | -1.88K% |
| March 31, 2025 | -312.0% |
| December 31, 2024 | -2.26K% |
| September 30, 2024 | -11.73K% |
| June 30, 2024 | -4.36K% |
| March 31, 2024 | -5.19K% |
| December 31, 2023 | -5.09K% |
| September 30, 2023 | -1.51K% |
| June 30, 2023 | -1.80K% |
| Date | Value |
|---|---|
| March 31, 2023 | |
| September 30, 2022 | -2.71K% |
| June 30, 2022 | -575.5% |
| March 31, 2022 | -898.2% |
| December 31, 2021 | -999.9% |
| September 30, 2021 | -1.40K% |
| June 30, 2021 | -516.9% |
| March 31, 2021 | -348.7% |
| December 31, 2020 | -1.25K% |
| September 30, 2020 | -1.22K% |
| June 30, 2020 | -6.37K% |
| March 31, 2020 | -48.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Precigen, Inc. | -34.10% |
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.02% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -108.2% |
| Gross Profit Margin (Quarterly) | -1.89K% |
| Operating Margin (Quarterly) | -32.28K% |
| Return on Net Operating Assets | -264.7% |